Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-07

Clinical Trial Update: ERP-Based Research on the Modulation of Remimazolam on Working Memory and Brain Network Mechanisms in Glioma Patients [NA]

View source ↗

Summary

A clinical trial update describing ERP-based research on how remimazolam may affect working memory and brain networks in glioma patients; the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Remimazolam Mild Sedation, Healthy Brain and Glioma Brain | NA | Status: NOT_YET_RECRUITING